Open-Label Study To Evaluate The EULAR-RAID Score, Rheumatoid Arthritis Impact Of Disease Score, In Rheumatoid Arthritis Patients Eligible To Etanercept And Who Will Receive Etanercept

The Disease Activity Score (DAS) is a system of measurement developed in the 1980s that uses
certain criteria, including joint counts and patient perceived disease activity, to measure
disease activity in people with Rheumatoid Arthritis . More recently, the European League
against Rheumatism (EULAR) has developed a new system of measurement known as the Rheumatoid
Arthritis Impact of Disease score, or EULAR-RAID score. The EULAR-RAID score is a composite
score based on patient reported outcomes, and includes such criteria as pain, functional
disability, fatigue, sleep disturbances, coping, overall assessment of physical well being
and overall assessment of psychological well being. The objective of this study is to
evaluate the practical modalities and performance of the EULAR- RAID score in patients with
rheumatoid arthritis who have been prescribed etanercept as part of usual medical practice.